Journals / MN Oftalmoloji / 1998 / Cilt: 5 - Sayı: 4

Intraoperative application of mitomycin C in primary and recurrent pterygium

Primer ve nüks pterjiumda cerrahi sırasında mitomisin C uygulaması

Pages
381–384
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: Intraoperative administration of mitomycin C is a simple and a more effective method than postoperative mitomycin therapy regarding lowest recurrence and complication rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE: To compare effect iven es and safety of intraoperative administration of mitomycin C and postoperative instillation of mitomycin C eye drops in primary and reccurent pterygium.
📊
Key Findings & Data:METHODS: One hundred and twelve patients (116 eyes) with primary and recurrent pterygium were operated using the bare sciera technique.
💡
Conclusion & Impact:CONCLUSION: Intraoperative administration of mitomycin C is a simple and a more effective method than postoperative mitomycin therapy regarding lowest recurrence and complication rates.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

PURPOSE: To compare effect iven es and safety of intraoperative administration of mitomycin C and postoperative instillation of mitomycin C eye drops in primary and reccurent pterygium. METHODS: One hundred and twelve patients (116 eyes) with primary and recurrent pterygium were operated using the bare sciera technique. Sixtyseven eyes of 62 patients (Group-l) after pterygium excision received mitomycin C 0.02% eye drops four times a day for one week. Mitomycin C (0.02%) was applied intraoperatively on the bare sciera for 4 minutes in 49 eyes (Group-ll) after pterygium excision. RESULTS: After a mean postoperative follow up of 14.88 months, 12 reccurences (17.9%) were observed in group-l eyes and 2 (4%) in group-ll eyes. Complications included in group-l; Scierai thinning in 6 eyes (8.9%), superficial punctat keratitis in 4 eyes (5.9%), purulan conjunctivitis in 2 eyes (2.9%), and corneal infiltration in 1 eye. Only scierai thinning was observed as complications in five of 49 patients (10.2%) in group-ll during the follow up period. CONCLUSION: Intraoperative administration of mitomycin C is a simple and a more effective method than postoperative mitomycin therapy regarding lowest recurrence and complication rates.

Özet

AMAÇ: Primer ve nüks pterjiumda %0.02 konsantrasyonda mitomisin C'nin ameliyat sırasında tek doz çıplak skiera alanına uygulanması ile ameliyattan sonra damla şeklinde uygulanmasının etkinlik ve güvenilirliğini karşılaştırmak. YÖNTEM: Primer ve nüks pterjiumlu 112 olgu (116 göz) çıplak skiera yöntemi kullanılarak ameliyat edildi. 63 olguya (67 göz) ameliyattan sonra %0.02 mitomisin C damlası 4x1/gün bir hafta boyunca verildi (Grup-l). 49 olguya (49 göz) ameliyat sırasında tek doz %0.02 konsantrasyonda mitomisin C uygulandı (Grup-ll). BULGULAR: Grup-l'de ortalama 14.88 ay izlem sonucunda 12 gözde (%17.9) nüks gelişti. Komplikasyon olarak grup-l'deki gözlerin 6'sında (%8.9) skiera incelmesi, 4'ünde (%5.9) punktat keratit, 2'sinde (%2.9) pürülan konjonktivit, 1'inde korneada mikroabse görüldü. Grup-H'de ortalama 15.9 aylık izlem sonucunda 2 (%4) gözde nüks gelişti. Komplikasyon olarak 5 gözde (%10.2) skiera incelmesi görüldü. SONUÇ: Nüks ve komplikasyon oranları karşılaştırıldığında mitomisin C'nin cerrahi sırasında uygulanması cerrahi sonrasında uygulamaya göre daha etkin ve güvenilir bulundu.

🔖

Cite This Article

ŞİMŞEK, T., GÜNALP, İ. (1998). Intraoperative application of mitomycin C in primary and recurrent pterygium. MN Oftalmoloji, Cilt: 5 - Sayı: 4, 381–384. https://ajindex.com/articles/297126